Área Sanitaria de Ferrol
Área sanitaria
Universidad Autónoma de Madrid
Madrid, EspañaPublicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (43)
2024
-
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort
Gastroenterologia y Hepatologia
-
Use of Darvadstrocel (Allogenic Stem Cell Therapy) for Crohn’s Fistulas in Real Clinical Practice: The National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn’s Fistula (the PRIME Study)
Diseases of the Colon and Rectum, Vol. 67, Núm. 7, pp. 960-967
2023
-
Adenovirus Infection in Hematopoietic and Solid Organ Paediatric Transplant Recipients: Treatment, Outcomes, and Use of Cidofovir
Microorganisms, Vol. 11, Núm. 7
-
Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study
Neurologia, Vol. 38, Núm. 6, pp. 379-386
-
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
Clinical Gastroenterology and Hepatology, Vol. 21, Núm. 3, pp. 771-788.e10
2022
-
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)
Journal of Clinical Medicine
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
Frontiers in Medicine, Vol. 9
2021
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
-
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas
Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819
2020
-
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease
United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066
-
PD-(L)1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: A pairwise meta-analysis
Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-13
-
Surgical treatment for colorectal cancer: Analysis of the influence of an enhanced recovery programme on long-term oncological outcomes-a study protocol for a prospective, multicentre, observational cohort study
BMJ Open, Vol. 10, Núm. 10
2019
-
Document on a comprehensive approach to type 2 diabetes mellitus
Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 7, pp. 443-458
2018
-
Current perspectives on the crosstalk between lung cancer stem cells and cancer-associated fibroblasts
Critical Reviews in Oncology/Hematology, Vol. 125, pp. 102-110
-
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
Clinical and Translational Allergy, Vol. 8, Núm. 1
-
Mechanisms of bacterial tolerance and persistence in the gastrointestinal and respiratory environments
Clinical Microbiology Reviews, Vol. 31, Núm. 4
-
Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain
European Journal of Gastroenterology and Hepatology, Vol. 30, Núm. 9, pp. 1060-1062
2016
-
Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up
Journal of the American College of Cardiology, Vol. 67, Núm. 11, pp. 1278-1285
-
Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)
Medicine (United States), Vol. 95, Núm. 9